CVS Health (CVS) Neutral Rating Kept by Baird; With $80 Target; Nuance Communications (NUAN) Has 0.95 Sentiment

February 9, 2018 - By Annabelle Johnson

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health has $132 highest and $73 lowest target. $97.35’s average target is 39.95% above currents $69.56 stock price. CVS Health had 70 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Robert W. Baird on Thursday, February 8. On Friday, December 18 the stock rating was initiated by Barclays Capital with “Overweight”. The stock has “Hold” rating by Jefferies on Wednesday, October 18. The firm has “Hold” rating by Robert W. Baird given on Wednesday, January 17. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Deutsche Bank on Thursday, August 20. The company was maintained on Thursday, December 17 by Oppenheimer. Citigroup maintained the shares of CVS in report on Thursday, August 17 with “Neutral” rating. Morgan Stanley upgraded the shares of CVS in report on Friday, January 5 to “Overweight” rating. The firm earned “Buy” rating on Monday, August 24 by Vetr. Robert W. Baird downgraded CVS Health Corporation (NYSE:CVS) rating on Thursday, February 2. Robert W. Baird has “Neutral” rating and $77 target.

Nuance Communications, Inc. provides voice recognition and natural language understanding solutions worldwide. The company has market cap of $4.76 billion. It operates through four divisions: Healthcare, Mobile, Enterprise, and Imaging. It currently has negative earnings. The Healthcare segment offers transcription solutions, which enables physicians to streamline clinical documentation with medical transcription platform; Dragon Medical, a dictation software that empowers physicians to accurately capture and document patient care in real-time on various devices; clinical document improvement and coding solutions to ensure patient health information is accurately documented, coded, and evaluated; and diagnostic solutions that allows radiologists to document, collaborate, and share medical images and reports.

Since January 1, 0001, it had 0 insider buys, and 3 selling transactions for $280,106 activity.

Ratings analysis reveals 100% of Nuance Communications’s analysts are positive. Out of 2 Wall Street analysts rating Nuance Communications, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. NUAN was included in 2 notes of analysts from November 18, 2016. As per Friday, January 6, the company rating was upgraded by Barclays Capital. The stock of Nuance Communications, Inc. (NASDAQ:NUAN) earned “Strong Buy” rating by Raymond James on Friday, November 18.

The stock decreased 0.55% or $0.09 during the last trading session, reaching $16.22. About 1.50M shares traded. Nuance Communications, Inc. (NUAN) has risen 16.56% since February 9, 2017 and is uptrending. It has underperformed by 0.14% the S&P500.

12Th Street Asset Management Company Llc holds 6.55% of its portfolio in Nuance Communications, Inc. for 1.61 million shares. Ivory Investment Management Llc owns 6.10 million shares or 4.77% of their US portfolio. Moreover, Shannon River Fund Management Llc has 4.28% invested in the company for 832,290 shares. The Massachusetts-based Sirios Capital Management L P has invested 4.13% in the stock. Mcrae Capital Management Inc, a New Jersey-based fund reported 330,250 shares.

Since August 16, 2017, it had 0 insider buys, and 7 selling transactions for $58.32 million activity. $18.88M worth of stock was sold by Denton David M on Monday, September 11. Another trade for 39,340 shares valued at $3.22M was sold by Foulkes Helena. The insider MERLO LARRY J sold 241,150 shares worth $20.03M. $7.19M worth of CVS Health Corporation (NYSE:CVS) was sold by Moriarty Thomas M on Monday, September 11. 85,743 shares valued at $7.13 million were sold by Roberts Jonathan C on Monday, September 18. SWIFT RICHARD J sold $199,050 worth of stock.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $70.47 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 14.33 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

The stock decreased 1.40% or $0.99 during the last trading session, reaching $69.56. About 2.90 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 9, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It dived, as 60 investors sold CVS Health Corporation shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Pennsylvania Trust invested 0.72% in CVS Health Corporation (NYSE:CVS). Trust Company Of Oklahoma stated it has 1.61% of its portfolio in CVS Health Corporation (NYSE:CVS). Coho Ptnrs invested in 4.49% or 2.15 million shares. Moreover, Amica Mutual has 0.48% invested in CVS Health Corporation (NYSE:CVS). Hl Financial Limited Liability accumulated 1.66M shares. Howland Mngmt Ltd holds 1.37% or 203,402 shares. Howe & Rusling has 0.03% invested in CVS Health Corporation (NYSE:CVS). Brandywine Investment Mgmt Lc reported 0.81% of its portfolio in CVS Health Corporation (NYSE:CVS). 145,295 are held by Cadence Capital Mgmt. Winslow Evans Crocker holds 5,260 shares or 0.14% of its portfolio. Homrich Berg accumulated 15,670 shares. Bb&T Secs Ltd Limited Liability Company holds 0.57% or 515,444 shares in its portfolio. Hemenway Tru Ltd Liability holds 2.65% in CVS Health Corporation (NYSE:CVS) or 156,214 shares. Robeco Institutional Asset Mngmt Bv holds 0.2% or 397,309 shares. Stevens First Principles Invest Advisors accumulated 39,951 shares or 1.77% of the stock.